Jane Street’s Oasmia Pharmaceutical AB OASM Stock Holding History

Jane Street’s Portfolio OASM Stock Details OASM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-11,855	Closed	-$27K	–	6107
2019 Q1	$27K	Sell	11,855 -44,720	-79%	-$123K	﹤0.01%	4886
2018 Q4	$175K	Buy	+56,575	New	+$223K	﹤0.01%	4520
2018 Q3	–	Sell	-26,771	Closed	-$37K	–	6032
2018 Q2	$37K	Buy	+26,771	New	+$39K	﹤0.01%	4842
2017 Q3	–	Sell	-64,454	Closed	-$68K	–	5325
2017 Q2	$68K	Buy	+64,454	New	+$114K	﹤0.01%	4208
2016 Q1	–	Sell	-10,590	Closed	-$40K	–	4876
2015 Q4	$40K	Buy	+10,590	New	+$41.6K	﹤0.01%	3890

Other funds holding OASM

CLOS

Compagnie Lombard Odier SCmA 1204 Geneva, Switzerland $9.25B AUM 27.04% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

FIA

FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return

Jane Street's OASM Position: Q2 2019 in Review

Jane Street sold out of Oasmia Pharmaceutical AB (OASM) in Q2 2019, closing a stake of 11,855 shares — an estimated $27K sold.

Jane Street first reported a position in OASM in Q4 2015 and held it in 5 quarters. The position peaked at $175K in Q4 2018. 4 funds tracked by Wall St. Rank hold OASM as of Q2 2019.

Jane Street reported no remaining Oasmia Pharmaceutical AB position as of Q2 2019 after selling out during the quarter.
Jane Street sold 11,855 Oasmia Pharmaceutical AB shares in Q2 2019, an estimated $27K.
Jane Street first reported a position in Oasmia Pharmaceutical AB in Q4 2015 and held it in 5 quarters.
Jane Street's Oasmia Pharmaceutical AB position peaked at $175K in Q4 2018.
4 funds tracked by Wall St. Rank held Oasmia Pharmaceutical AB as of Q2 2019.

Based on Jane Street's 13F filing for Q2 2019, filed 15 Aug 2019.